Sign in / Join Now
ETFs & Funds
Its all about medical stocks. Some beautiful bases and breakouts out there:
Add a reply...
Latest StockTalks »
people get MRK breaking news and analysis by email alert.
Get email alerts on MRK »
Merck & Co Inc.
Get latest price
From other sites
Merck Announces Fourth-Quarter 2017 Dividend
at TheStreet (Tue, 3:57PM)
Merck's Investigational NNRTI, Doravirine, Meets Primary Efficacy Endpoint Of Non-Inferiority To Efavirenz, Both In Combination With Other Antiretroviral Agents, In Pivotal Phase 3 Trial For Treatment Of HIV-1 Infection
at TheStreet (Tue, 8:35AM)
Merck a Top Socially Responsible Dividend Stock With 3.0% Yield (MRK)
at Nasdaq.com (Tue, 8:10AM)
Analysts’ Recommendations for Merck in July 2017
at MarketRealist.com (Tue, 7:35AM)
Merck Provides Update On Phase 3 Study Of KEYTRUDA® (pembrolizumab) Monotherapy In Patients With Previously Treated Recurrent Or Metastatic Head And Neck Squamous Cell Carcinoma (HNSCC)
at TheStreet (Mon, 5:00PM)